Fieldpoint Private Securities LLC bought a new stake in Metlife Inc (NYSE:MET) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,365 shares of the financial services provider’s stock, valued at approximately $175,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MET. Chesley Taft & Associates LLC grew its stake in Metlife by 1.4% in the second quarter. Chesley Taft & Associates LLC now owns 38,725 shares of the financial services provider’s stock valued at $2,128,000 after purchasing an additional 545 shares in the last quarter. Franklin Street Advisors Inc. NC boosted its stake in shares of Metlife by 6.3% during the 2nd quarter. Franklin Street Advisors Inc. NC now owns 141,598 shares of the financial services provider’s stock worth $7,779,000 after acquiring an additional 8,365 shares in the last quarter. BTR Capital Management Inc. boosted its stake in shares of Metlife by 2.0% during the 2nd quarter. BTR Capital Management Inc. now owns 169,752 shares of the financial services provider’s stock worth $9,326,000 after acquiring an additional 3,268 shares in the last quarter. Mn Services Vermogensbeheer B.V. boosted its stake in shares of Metlife by 515.6% during the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 153,375 shares of the financial services provider’s stock worth $8,426,000 after acquiring an additional 128,459 shares in the last quarter. Finally, LVM Capital Management Ltd. MI boosted its stake in shares of Metlife by 1.4% during the 2nd quarter. LVM Capital Management Ltd. MI now owns 5,395 shares of the financial services provider’s stock worth $296,000 after acquiring an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 76.37% of the company’s stock.

Shares of Metlife Inc (NYSE MET) traded down $0.35 during trading hours on Friday, reaching $52.49. The company had a trading volume of 4,281,700 shares, compared to its average volume of 5,689,550. Metlife Inc has a 1 year low of $44.26 and a 1 year high of $55.91. The company has a market cap of $55,587.69, a P/E ratio of 10.16, a price-to-earnings-growth ratio of 1.33 and a beta of 1.49. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16.

Metlife (NYSE:MET) last announced its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.19. Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The firm had revenue of $16.10 billion during the quarter, compared to the consensus estimate of $15.47 billion. During the same quarter in the prior year, the company earned $1.28 EPS. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. research analysts predict that Metlife Inc will post 4.43 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 13th. Investors of record on Monday, November 6th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 3rd. This represents a $1.60 annualized dividend and a yield of 3.05%. Metlife’s payout ratio is -320.00%.

Several analysts have recently issued reports on the company. Wells Fargo & Company set a $62.00 price target on Metlife and gave the stock a “buy” rating in a research note on Thursday. Sandler O’Neill downgraded Metlife from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. ValuEngine downgraded Metlife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 9th. Zacks Investment Research upgraded Metlife from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research note on Thursday, November 9th. Finally, B. Riley reiterated a “neutral” rating on shares of Metlife in a research note on Monday, November 6th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Metlife currently has a consensus rating of “Buy” and a consensus price target of $58.52.

In other Metlife news, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $54.60, for a total value of $4,517,112.60. Following the completion of the transaction, the insider now owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $54.29, for a total value of $3,024,604.48. Following the completion of the transaction, the insider now directly owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. 0.32% of the stock is owned by corporate insiders.

WARNING: “Fieldpoint Private Securities LLC Takes Position in Metlife Inc (MET)” was posted by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.watchlistnews.com/fieldpoint-private-securities-llc-takes-position-in-metlife-inc-met/1765913.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with Analyst Ratings Network's FREE daily email newsletter.